Short answer
LifeStance Health Group, Inc. (LFST) filed an 8-K current report with the SEC on March 11, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Lisa Miller promoted to COO effective March 10, 2026, previously EVP Practice Operations since Feb 2024: internal promotion signals continuity.
LifeStance Health Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Lisa Miller promoted to COO effective March 10, 2026, previously EVP Practice Operations since Feb 2024: internal promotion signals continuity
- Annual base salary set at $485,000 with target bonus of 85% of base (~$412,250), implying total cash target ~$897,250
- Annual equity award of ~$1,500,000 in RSUs (mix of time-based and performance-based), vesting over 3 years
- Performance RSUs tied to achievement of undisclosed targets: alignment with operational execution critical for a behavioral health operator scaling clinician capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeStance Health Group, Inc. 8-K filings
Get the next LFST 8-K as it lands
Follow LFST for push alerts, or ask the research agent what this filing means.